Misuse of serum matrix metalloproteinase (MMP)-9 and tissue inhibitor of metalloproteinase (TIMP)-1 as a biomaker in multiple sclerosis

Multiple Sclerosis

Volumn 12, Issue 1, 2006, Pages 120-

  Gerlach, Raquel F ^a   Tanus Santos, Jose E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; BIOLOGICAL MARKER; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

DIAGNOSTIC VALUE; DISEASE ACTIVITY; HUMAN; LETTER; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA; PROTEIN BLOOD LEVEL; RELAPSE; RELIABILITY; REMISSION; SERUM;

BIOLOGICAL MARKERS; HUMANS; MATRIX METALLOPROTEINASE 9; MULTIPLE SCLEROSIS; REPRODUCIBILITY OF RESULTS; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 31644448168     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135248506ms1281xx     Document Type: Letter

References (7)

1. Avolio C, Filippi M, Tortorella C, Rocca MA, Ruggieri M, Agosta F et al. Serum MMP-9/TIMP-1 and MMP-2/TIMP-2 ratios in multiple sclerosis: relationships with different magnetic resonance imaging measures of disease activity during IFN-beta-1a treatment. Mult Scler 2005; 11: 441-46.
2. Jung K, Lein M, Laube C, Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 2001; 314: 241-44.
3. Jung K, Laube C. Lein M, Lichtinghagen R, Tschesche H, Schnorr D et al. Kind of sample as preanalytical determinant of matrix metalloproteinase 2 and 9 and tissue inhibitor of metalloproteinase 2 in blood. Clin Chem 1998; 44: 1060-62.
4. Makowski GS, Ramsby ML. Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma. Anal Biochem 2003; 322: 283-86.
5. Gerlach RF, Uzuelli JA, Souza-Tarla CD, Tanus-Santos JE. Effect of anticoagulants on plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 2005; 344: 147-49.
6. Souza-Tarla CD, Uzuelli JA, Machado AA, Gerlach RF, Tanus-Santos JE. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 2005; 38: 410-14.
7. Tanus-Santos JE, Gerlach RF. Circulating matrix metalloproteinase-9 levels as a possible marker of aortic stiffness. Arterioscler Thromb Vasc Biol 2005; 25: c27 (Letter).